Personalized immune cell vaccine for glioblastoma
Treatments studied
Part of Cancer clinical trials.
This trial tests a vaccine made from your own immune cells to fight glioblastoma, a type of brain cancer. It may help your body attack the cancer more effectively after standard treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of glioblastoma, a type of brain cancer.
- You need to have completed standard treatments: surgery, chemotherapy, and radiation therapy.
- You must have had an MRI before treatment started.
- You should be able to attend follow-up visits every 2 months.
- You need to be in fairly good health and able to care for yourself.
- You cannot have other cancers (except a common skin cancer), be pregnant, or have a weakened immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental 'vaccine' made from your own immune cells (dendritic cells). The vaccine is designed to train your immune system to attack the brain tumor. It is for people whose glioblastoma has returned or progressed after standard treatment.
This trial tests a personalized vaccine (made from your own cells) combined with a common chemotherapy drug, temozolomide, for people with newly diagnosed glioblastoma. The goal is to train your immune system to fight the tumor and hopefully slow its growth.
This trial is testing a new vaccine (Bvax) added to the usual chemotherapy and radiation for glioblastoma. It aims to train your immune system to fight the tumor and possibly improve outcomes.
This study is testing a new type of immune cell therapy (cytokine-induced killer cells) for people with glioblastoma, a type of brain cancer. The treatment may boost your immune system to fight the cancer.
This trial tests an experimental immunotherapy made from your own immune cells, designed to train them to attack a protein (survivin) found in glioblastoma. It is a phase 1 study, meaning it is one of the first times this treatment is being tested in people, and it is given alongside standard radiation and chemotherapy.
This trial tests a personalized vaccine made from your own immune cells that targets a protein (survivin) found on your tumor. It is given alongside the standard radiation and chemotherapy to see if it helps fight the cancer.
Hear when a new Glioblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.